GlaxoSmithKline logo

Patient group funding

European Patients' Forum (EPF)

The vision of EPF is to ensure that the European patient voice is at the centre of healthcare. EPF works as a catalyst for advocating a strong European patient voice, enabling patient groups to join forces and develop alliances. They work with like-minded stakeholders and with the EU institutions.

We have supported this organisation since 2005.

During 2010:

  • We gave an unrestricted grant of €40,000 to help them with their activities.
  • In addition, we gave an educational grant of €30,000 to support EPF's Conference planned for July 2011.

Our support represents 9.94% of their overall income. (Subject to final audited figures).



During 2009:

  • We gave an unrestricted grant of €40,000 to help them with their activities.
  • Also we gave EPF two honoraria of €500 to support the attendance of the Director General at GSK’s European Health Advisory Board meetings. 
  • In addition, we gave an educational grant of €30,000 to support EPF's Conference planned for May 2010

Our support represents 9.3% of their overall income.



During 2008:

  • We gave an unrestricted grant of €40,000 to support their activities
  •  We also gave EPF two honoraria of €500 to support the attendance of the Director General at GSK’s European Health Advisory Board meetings
  • In addition we gave an educational grant of €40,000 to support EPF's annual Conference planned for December 2009  

Our support represents 13.49% of their overall income.


During 2007:

  • We gave an unresticted grant of €40,000 to help them with their activities 
  • We gave an educational grant of €36,250 to help support EPF's 2007 spring conference (second payment) 
  • We gave an educational grant of €50,000 to support EPF's spring conference planned for April 2008
  • We also gave EPF two honoraria of €500 to support the attendance of the Director General at GSK’s European Health Advisory Board meetings.  

Our support represented 25.3% of their income overall.



In 2006:

  • We provided €35,000 as an unrestricted grant to help support their activities.
  • We gave an additional unrestricted grant of €36,250 to support EPF's spring conference planned for 2007.
  • We also gave EPF an honorarium of €500 to support the attendance of the Director General at GSK's European Health Advisory Board meeting.

Our support represented 17% of their income overall.